Our results demonstrate the interaction between endogenous ITGB6 and EGFR in the NSCLC cell line A549, whereas endogenous ITGB2 interacts with pEGFR in the SCLC cell line NCI-H196. Here, ITGB6 is linked to small cell lung carcinoma.